Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Paragraph: Shares of the company traded marginally down at $132.47, after having closed up 1.7% on Monday. (bit.ly/2ZkZGze)    J&J said that the FTC had issued a “civil investigative demand,” or CID, the equivalent of a subpoena to determine if the contracting practices were legal. Pfizer Inc filed a lawsuit against J&J in 2017, saying its rival’s contracts with health insurers for blockbuster rheumatoid arthritis drug, Remicade, were anticompetitive and aimed at blocking sales of Pfizer’s biosimilar called Inflectra. Pfizer said in the lawsuit that J&J had contracted with many insurers to give discounts in exchange for giving preference to Remicade, and to only pay for Inflectra in cases where Remicade proved to be ineffective. Inflectra was approved in 2016 while Remicade went on the market in 1998. Remicade is an infused treatment for chronic autoimmune disorders and costs about $4,000 per dose, or $26,000 a year, Pfizer said in the lawsuit. J&J has denied any wrongdoing and is fighting the Pfizer lawsuit. Pfizer said in a statement that it had received a CID in June. “As Pfizer’s complaint alleges, J&J’s unlawful conduct is designed to prevent Inflectra from being able to compete on its primary point of differentiation – price. Today, Inflectra has an average selling price (ASP) that is more than 22% lower than Remicade,” the company said in a statement. “Despite these facts, J&J has not lost substantial volume or share of sales – counter to what should occur in a competitive market.”  Biosimilars are intended to be lower-cost alternatives to expensive biotech medicines. But since they are made from living cells and it is not possible to make an exact copy of the branded medicine, they are not automatically substituted for the existing branded drug the way a generic drug would be. The drugs treat ailments like rheumatoid arthritis, Crohn’s disease and ulcerative colitis. Claim: J&J says FTC probing efforts to protect arthritis drug Remicade.
The Federal Trade Commission issued civil subpoenas to Johnson and Johnson in June as part of an investigation into whether contracting practices for its blockbuster rheumatoid arthritis drug, Remicade, violated antitrust laws, the company said in a regulatory filing on Monday.

Paragraph: Grown in-vitro from cattle stem cells at a cost of 250,000 euros ($332,000), the burger was cooked and eaten in front of television cameras to gain the greatest media coverage for the culmination of a five-year science experiment. Resembling a standard circular-shaped red meat patty, it was created by knitting together 20,000 strands of laboratory-grown protein, combined with other ingredients normally used in burgers, such as salt, breadcrumbs and egg powder. Red beet juice and saffron were added to give it colour. The two food tasters were reserved in their judgement, perhaps keen not to offend their host at the London event, noting the burger’s “absence of fat”. Pressed for a more detailed description of the flavour, food writer Josh Schonwald said the cultured beef had an “animal protein cake” like quality to it, adding that he would like to try it with some of the extras often served with traditional burgers - salt, pepper, ketchup and jalepenos. Even the scientist behind the burger’s creation, vascular biologist Mark Post of Maastricht University in the Netherlands, was relatively muted in his praise of its flavour. “It’s a very good start,” he told the hundreds of reporters who had gathered to watch the meat being cooked and served. The Dutch scientist’s aim was to show the world that in the future meat will not necessarily have to come from the environmentally and economically costly rearing and slaughtering of millions of animals. “Current meat production is at its maximum - we need to come up with an alternative,” he said. The World Health Organization (WHO) says meat production is projected to rise to 376 million tonnes by 2030 from 218 million tonnes annually in 1997-1999, and demand from a growing world population is expected to rise beyond that. According to a 2006 report by the U.N. Food and Agriculture Organization (FAO), industrialised agriculture contributes on a “massive scale” to climate change, air pollution, land degradation, energy use, deforestation and biodiversity decline. The meat industry contributes about 18 percent of global greenhouse gas emissions, a proportion expected to grow as consumers in fast-developing countries such as China and India eat more meat, the report said. Chris Mason, a professor of regenerative medicine at University College London, who was not involved in the research, said it was “great pioneering science” with the potential to ease environmental, health and animal welfare problems. But, he added: “whilst the science looks achievable, the scalable manufacturing will require new game-changing innovation”. Post said he was confident his concept can be scaled up to offer a viable alternative to animal meat production, but said it may be another 20 years before lab-grown meat appears on supermarket shelves. He also conceded that the flavour of his meat must be improved if it is to become a popular choice. Post resisted requests from journalists from all over the world eager to try a morsel of the world’s first cultured beef burger, saying there was not enough to go around. Instead, he said, his children would be offered the leftovers. ($1 = 0.7528 euros) Claim: First taste of test-tube burger declared 'close to meat'.
The world’s first laboratory-grown beef burger was flipped out of a petri dish and into a frying pan on Monday, with food tasters declaring it tasted “close to meat”.

Paragraph: Agriculture Commissioner Sid Miller last month halted the use of 15 cattle fever tick spray boxes in South Texas for lacking ventilation, the Waco Tribune-Herald reported. The boxes spray livestock with a chemical to eliminate ticks that spread bovine babesiosis. The disease kills 90 percent of the animals it infects, according to the Texas Animal Health Commission. But Miller said he’s received reports of cattle dying from the boxes’ poorly ventilated units. Nearly 920 cattle have been exposed to fever ticks in 82 counties since September 2016, the state Animal Health Commission said. “Portable spray boxes have been utilized for decades and have proven very effective in our containment and eradication efforts,” said commission director Andy Schwartz. Cattle raisers need a short-term solution to prevent their livestock from contracting the disease, said Gene Hall, Texas Farm Bureau spokesman. “They need to be spraying right now,” Hall said. “Every day they miss, cattle are being put in jeopardy.” Austin Brown III, director of the Texas and Southwest Cattle Raisers, has ranched cattle with his family in Bee County for decades. “Without tools to control these ticks, we run the risk of their spreading northward,” Brown said. “I’ve never had any trouble with spray boxes, and without their use, I believe there is a threat to local and state herds, even beyond.” Miller planned to meet this week with representatives of the animal health commission and the U.S. Department of Agriculture to discuss the issue. But representatives failed to show, said agency spokesman Mark Loeffler. “It’s hard to make a deal with thin air,” Miller wrote. “I’ve got a proposal to get those spray boxes open again, but everyone has to come to the table.” ___ Information from: Waco Tribune-Herald, http://www.wacotrib.com Claim: Texas cattle groups dispute over tick treatment ban.

A recent decision to ban a tool to treat a deadly tick could put cattle at risk, according to Texas ranchers and several government agencies.